ARTL

Ladenburg Thalmann to Host R&D Showcase Featuring Artelo Biosciences' CAReS Study on July 28, 2021

Artelo Biosciences Reports Third Quarter Fiscal 2021 Financial Results and Provides Business Update

Relief For Cancer Patients In Artelo Bioscience Pipeline

Artelo Biosciences to Present at the LD Micro Virtual Invitational XI on June 9th

Artelo Biosciences Reports Second Quarter Fiscal 2021 Financial Results and Provides Business Update

Artelo Biosciences Doses First Patient in CAReS Study with ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss

Artelo Biosciences, Inc. (ARTL) CEO Gregory Gorgas Presents at Q1 Virtual Investor Summit Conference (Transcript)